Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexRUT P/E19.47 EPS (ttm)4.29 Insider Own1.31% Shs Outstand49.51M Perf Week-2.00%
Market Cap4.12B Forward P/E16.61 EPS next Y5.02 Insider Trans-2.86% Shs Float48.77M Perf Month-4.71%
Income214.60M PEG4.12 EPS next Q1.00 Inst Own105.76% Short Float3.76% Perf Quarter-1.09%
Sales1.14B P/S3.62 EPS this Y5.51% Inst Trans-1.47% Short Ratio5.03 Perf Half Y1.77%
Book/sh37.06 P/B2.25 EPS next Y5.34% ROA6.30% Short Interest1.83M Perf Year28.65%
Cash/sh1.98 P/C42.12 EPS next 5Y4.72% ROE12.30% 52W Range64.63 - 90.04 Perf YTD6.85%
Dividend Est.- P/FCF16.95 EPS past 5Y9.02% ROIC7.48% 52W High-7.33% Beta0.46
Dividend TTM- Quick Ratio2.82 Sales past 5Y3.39% Gross Margin53.89% 52W Low29.10% ATR (14)1.59
Dividend Ex-DateDec 27, 2013 Current Ratio4.20 EPS Y/Y TTM2.65% Oper. Margin30.70% RSI (14)43.43 Volatility0.19% 0.87%
Employees600 Debt/Eq0.57 Sales Y/Y TTM1.10% Profit Margin18.86% Recom2.17 Target Price93.25
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q1.85% Payout0.00% Rel Volume0.99 Prev Close83.64
Sales Surprise2.41% EPS Surprise1.66% Sales Q/Q7.05% EarningsMay 08 BMO Avg Volume364.32K Price83.44
SMA20-1.66% SMA50-0.49% SMA2004.03% Trades Volume362,361 Change-0.24%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Downgrade Sidoti Buy → Neutral $90
Jun-21-24Upgrade DA Davidson Neutral → Buy $65 → $93
Nov-17-22Initiated Canaccord Genuity Buy $71
May-10-22Upgrade Jefferies Hold → Buy $65 → $70
May-09-22Upgrade Oppenheimer Perform → Outperform $63
Aug-07-20Downgrade DA Davidson Buy → Neutral
Jun-29-20Upgrade Sidoti Neutral → Buy
Apr-14-20Downgrade Jefferies Buy → Hold
Apr-07-20Resumed Sidoti Neutral $46
Mar-26-20Upgrade Jefferies Hold → Buy $43
Jun-17-25 05:38PM
Jun-13-25 11:21AM
08:27AM
Jun-11-25 09:51AM
08:35AM
04:30PM Loading…
Jun-09-25 04:30PM
08:37AM
Jun-06-25 09:02AM
Jun-03-25 10:09AM
09:40AM
Jun-02-25 10:23AM
10:18AM
09:50AM
May-30-25 11:40AM
10:09AM
09:27AM Loading…
09:27AM
08:16AM
May-29-25 08:54AM
08:47AM
May-28-25 08:12AM
May-27-25 08:15AM
May-26-25 08:38AM
08:30AM
08:30AM
May-23-25 08:53AM
May-22-25 06:46AM
06:38AM
May-21-25 11:36AM
07:49AM
May-20-25 08:53AM
08:49AM Loading…
08:49AM
May-15-25 07:01PM
May-14-25 11:40AM
May-13-25 09:41AM
May-09-25 03:17AM
May-08-25 02:55PM
09:30AM
07:20AM
07:09AM
06:00AM
May-07-25 09:46AM
09:15AM
May-01-25 10:01AM
Apr-30-25 07:30AM
Apr-28-25 01:26PM
11:40AM
Apr-17-25 09:52AM
Apr-10-25 05:00PM
11:40AM
Apr-08-25 07:05PM
Apr-03-25 11:47AM
Mar-31-25 04:03PM
Mar-27-25 09:07AM
Mar-25-25 08:11AM
Feb-07-25 02:11AM
Feb-06-25 03:53PM
06:00AM
Feb-05-25 07:07AM
Jan-21-25 07:12PM
Jan-09-25 08:00AM
Jan-06-25 07:08PM
08:00AM
Nov-11-24 12:00PM
Nov-08-24 02:13AM
Nov-07-24 11:12AM
06:00AM
Nov-06-24 07:09PM
07:09AM
Oct-11-24 08:58AM
Oct-09-24 05:34PM
Oct-08-24 08:00AM
Sep-20-24 08:50AM
Sep-17-24 08:00AM
Sep-04-24 08:50AM
Sep-03-24 08:00AM
Aug-08-24 05:28PM
06:00AM
Jul-02-24 04:30PM
Jun-13-24 11:30AM
Jun-06-24 04:30PM
May-16-24 11:36AM
03:02AM
May-15-24 12:19PM
May-14-24 09:53PM
06:15PM
05:00PM
May-09-24 09:15AM
May-06-24 06:17PM
Apr-25-24 10:02AM
08:30AM
Apr-19-24 07:41AM
Apr-08-24 09:40AM
Apr-03-24 11:57AM
Apr-02-24 09:06AM
Mar-25-24 09:50AM
Mar-21-24 10:40AM
Mar-05-24 12:55PM
Feb-29-24 09:50AM
Feb-16-24 05:00PM
Feb-08-24 05:34PM
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fritz Mary BethSVP Quality & RegulatoryMar 10 '25Sale90.001,678151,02017,157Mar 12 04:01 PM
Fritz Mary BethOfficerMar 10 '25Proposed Sale90.001,678151,020Mar 10 01:05 PM
Fritz Mary BethSVP Quality & RegulatoryMar 03 '25Option Exercise44.336,297279,14625,132Mar 05 04:01 PM
Fritz Mary BethSVP Quality & RegulatoryMar 03 '25Sale85.396,297537,70118,835Mar 05 04:01 PM
Fritz Mary BethOfficerMar 03 '25Proposed Sale85.396,297537,725Mar 03 04:11 PM
Mekhail AdelEVP, Marketing & SalesFeb 11 '25Option Exercise49.5311,083548,93524,048Feb 13 04:01 PM
Mekhail AdelEVP, Marketing & SalesFeb 11 '25Sale86.5511,083959,27118,365Feb 13 04:01 PM
Mekhail AdelOfficerFeb 11 '25Proposed Sale86.2111,083955,509Feb 11 04:08 PM
Lombardi Ronald M.Chief Executive OfficerNov 19 '24Option Exercise56.6210,875615,774326,614Nov 21 04:01 PM
Lombardi Ronald M.Chief Executive OfficerNov 19 '24Sale82.6010,875898,241320,952Nov 21 04:01 PM
Lombardi Ronald M.OfficerNov 19 '24Proposed Sale81.5810,875887,187Nov 19 04:12 PM
Lombardi Ronald M.Chief Executive OfficerNov 18 '24Option Exercise56.7482,2374,666,226369,464Nov 19 04:01 PM
Lombardi Ronald M.Chief Executive OfficerNov 18 '24Sale82.5682,2376,789,764320,952Nov 19 04:01 PM
Lombardi Ronald M.OfficerNov 18 '24Proposed Sale81.7682,2376,723,553Nov 18 05:15 PM
P'Pool WilliamSee RemarksNov 12 '24Sale81.858,987735,58620,058Nov 14 07:42 PM
Sacco ChristineChief Financial OfficerNov 12 '24Option Exercise30.5624,686754,40454,809Nov 14 07:42 PM
Sacco ChristineChief Financial OfficerNov 12 '24Sale82.0124,6862,024,49930,123Nov 14 07:42 PM
Mekhail AdelEVP, Marketing & SalesNov 12 '24Option Exercise44.335,565246,69627,428Nov 14 07:41 PM
Mekhail AdelEVP, Marketing & SalesNov 12 '24Sale82.009,063743,16618,365Nov 14 07:41 PM
Fritz Mary BethSVP Quality & RegulatoryNov 12 '24Sale81.979,885810,26618,835Nov 14 07:39 PM
P'Pool WilliamOfficerNov 12 '24Proposed Sale81.858,987735,612Nov 12 04:07 PM
Sacco ChristineOfficerNov 12 '24Proposed Sale82.0124,6862,024,538Nov 12 02:35 PM
Fritz Mary BethOfficerNov 12 '24Proposed Sale81.979,885810,300Nov 12 02:29 PM
Mekhail AdelOfficerNov 12 '24Proposed Sale82.009,063743,135Nov 12 02:11 PM